Table 3.
Estimated carcinogenic risks through ingestion, inhalation, and dermal pathways for children and adults.
Adult | Children | |||||||
---|---|---|---|---|---|---|---|---|
Carcinogenic | CRingestion | CRinhalation | CRdermal | TCR | CRingestion | CRinhalation | CRdermal | TCR |
As | 4.8E-06 | 2.5E-07 | 6.8E-07 | 5.8E-06 | 4.5E-05 | 1.2E-07 | 5.4E-07 | 4.7E-05 |
Cd | 6.9E-06 | 6.1E-11 | – | 6.9E-06 | 6.4E-05 | 2.8E-10 | – | 6.4E-05 |
Co | – | 1.2E-10 | – | 1.2E-10 | – | 5.6E-10 | – | 5.6E-10 |
Cr | 7.4E-05 | 1.3E-10 | 3.5E-08 | 7.4E-05 | 6.9E-04 | 6.0E-10 | 2.8E-08 | 6.9E-04 |
Ni | 1.7E-05 | 4.4E-09 | 6.8E-08 | 1.7E-05 | 1.6E-04 | 2.1E-08 | 5.5E-08 | 1.6E-04 |
Total | 1.0E-04 | 2.5E-07 | 7.8E-07 | 1.0E-04 | 9.5E-04 | 1.2E-06 | 6.3E-07 | 9.6E-04 |